Boulogne, France

Gérard Duret


Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2008-2014

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Gérard Duret in Asymmetric Synthesis

Introduction

Gérard Duret is a notable inventor based in Boulogne, France. He has made significant contributions to the field of asymmetric synthesis, particularly in the development of methods for producing enantiomerically pure compounds. With a total of three patents to his name, Duret's work has implications in pharmaceuticals and chemical manufacturing.

Latest Patents

One of Gérard Duret's latest patents is focused on the "Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation." This invention relates to a method for preparing a sulphoxide compound, either as a single enantiomer or in an enantiomerically enriched form. The process involves specific steps that enhance the efficiency and selectivity of the synthesis.

Career Highlights

Duret is currently associated with Cephalon France, where he applies his expertise in asymmetric synthesis to advance the company's research and development efforts. His innovative approaches have contributed to the enhancement of pharmaceutical products, particularly in the area of enantiomerically pure drugs.

Collaborations

Throughout his career, Gérard Duret has collaborated with esteemed colleagues such as François Rebiere and Laurence Prat. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of innovative solutions in the field of chemistry.

Conclusion

Gérard Duret's contributions to asymmetric synthesis and his innovative patents highlight his role as a significant figure in the field of chemistry. His work continues to influence the development of pharmaceutical compounds, showcasing the importance of innovation in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…